Global Manufacturing Presence ROVI Pharma Industrial Services has expanded its footprint with a recent asset acquisition in the United States through the purchase of a pharmaceutical manufacturing plant, enabling local production and supply chain flexibility for North American clients.

Regulatory Compliance & Approvals The company's operations are approved by major international regulatory agencies including FDA, EMA, and others, which facilitates access to global markets and positions ROVI as a trusted partner for international pharmaceutical and biotech companies seeking compliant manufacturing solutions.

Specialized Aseptic Capabilities With over 25 years of expertise in aseptic fill-finish for injectables such as vaccines and biologics, ROVI offers high-capacity, flexible manufacturing lines, making it an ideal partner for clients developing or scaling biologic and vaccine products.

Recent Leadership & Investment The appointment of a new Chief Commercial Officer and ongoing investments in manufacturing infrastructure highlight ROVI’s focus on strengthening its market position and expanding its capabilities to attract new customers and retain existing ones.

Market and Industry Focus Operating with a revenue range of $50 million to $100 million and serving over 80 countries, ROVI is well-positioned to target mid-sized pharmaceutical and biotech firms looking for reliable CDMO services, especially those in biologics, vaccines, and sterile injectables.